Login to Your Account



Other News To Note


Wednesday, April 3, 2013

• Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., returned sponsorship of Urocidin, a Phase III bladder cancer candidate, to Bioniche Life Sciences Inc., of Belleville, Ontario, according to an agreement made in December.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription